Evidence map›Paper›PMID 40158181›Full record

ArticleWorld journal of surgical oncology2025

SMARCA4-deficient non-small cell lung cancer with metastasis to the sigmoid colon: a case report.

Rong Xiao, Guang Fu, Xinglan Li, Tao Lu

Abstract readCase Reports
In one paragraph

Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rong Xiao *Department of Radiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, 32 West Second Section, First Ring Road, Chengdu, 610072, China.
Guang Fu *Department of Radiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, 32 West Second Section, First Ring Road, Chengdu, 610072, China.
Xinglan LiDepartment of Pathology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, 32 West Second Section, First Ring Road, Chengdu, 610072, China.
Tao LuDepartment of Radiology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, 32 West Second Section, First Ring Road, Chengdu, 610072, China. tao.lulu@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) is a rare subtype of NSCLC whose definitive radiographic characteristics have not yet been fully delineated. Clinically, these tumors often metastasize to distant organs and lymph nodes at an early stage, which is strongly associated with poor clinical prognosis. The common metastatic sites include bone, brain, adrenal glands, liver, and spleen, whereas intestinal metastasis is extremely rare. In this case, we describe a rare instance of SMARCA4-deficient NSCLC with metastasis to the sigmoid colon. CASE DESCRIPTION: A 59-year-old male presented with hoarseness and shortness of breath. Computed tomography (CT) imaging revealed an irregular mass in the posterior apical segment of the upper lobe of the left lung, with enlarged lymph nodes in the mediastinum and left lung hilum. A biopsy of the lung mass confirmed the diagnosis of NSCLC with SMARCA4 gene deletion. CT also revealed uneven thickening of the sigmoid colon wall, which was proved to be metastases from the lung cancer through surgical pathology. The patient initially underwent chemotherapy combined with immunotherapy and intensity-modulated radiotherapy for the lungs. However, a follow-up CT revealed progression in the sigmoid colon tumor. Consequently, the patient underwent laparoscopic radical sigmoid colectomy with regional lymph node dissection. Two months postoperatively, metastasis to the left adrenal gland was detected. The treatment regimen was adjusted to a combination therapy consisting of gemcitabine, nedaplatin, bevacizumab, and camrelizumab accordingly. The patient demonstrated a favorable response to this treatment, with no evidence of recurrence or further metastasis to date.

conclusionsThis case represents the first reported instance of SMARCA4-dNSCLC with metastasis to the sigmoid colon. The atypical clinical and radiological features of this condition pose significant diagnostic challenges, particularly in differentiating metastatic lesions from primary colonic tumors. This case underscores the significance of recognizing rare metastatic patterns in SMARCA4-dNSCLC, enriching the literature on its diverse manifestations and providing a critical reference for clinicians in diagnosing and managing SMARCA4-dNSCLC with sigmoid colon metastasis.

Indexed as

Carcinoma, Non-Small-Cell LungDNA HelicasesLung NeoplasmsNuclear ProteinsSigmoid NeoplasmsTranscription FactorsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleMiddle AgedPrognosisTomography, X-Ray ComputedTranscription Factor 4DNA HelicasesNuclear ProteinsSMARCA4 protein, humanTranscription Factor 4Transcription FactorsCase reportComputed tomographyImmunohistochemistryNon-small cell lung cancerRare metastatic sitesSMARCA4-deficient

Identifiers

PMID40158181
PMCPMC11954277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.